Latest Conference Articles

Global Biopharma Leaders to Shape Industry Outlook at BIO-Europe 2025

September 24th 2025

Vienna to host BIO-Europe 2025, connecting top biopharma companies for collaborations and pipeline development.

CPHI Frankfurt Reveals 2025 Pharma Awards Finalists for Bio/Pharma Development

September 18th 2025

Finalists for CPHI Frankfurt Pharma Awards 2025 showcase innovation in drug development, advanced manufacturing, and future industry leaders.

ABC Farmaceutici to Mark 100th Anniversary with CPHI Frankfurt Display

September 18th 2025

CPHI Europe

The company, under parent ICE Pharma, will celebrate its past achievements, present its expertise and plans for the future, and unveil a “100 Years” logo.

Sanner Previews CPHI Frankfurt Portfolio of CDMO Services, Packaging Innovations

September 17th 2025

CPHI Europe

The company has expanded its CDMO offerings in recent years, adding to decades of experiences in solutions such as moisture management.

CPHI Frankfurt Expected to Draw More Than 60,000 Attendees in October

September 12th 2025

CPHI Europe

The 2024 edition of the annual conference, held in Milan, attracted more than 59,000 professionals from across the bio/pharmaceutical landscape.

Driving Quality from the Top: Merck Manufacturing Leader’s Pitch to PDA Regulatory Conference Audience

September 11th 2025

PDA Regulatory Conference

Merck’s Sanat Chattopadhyay called for stronger leadership, data-driven oversight, and shared accountability to raise pharmaceutical quality standards.

PDA Regulatory Conference 2025: Wrap Up

September 11th 2025

Susan J. Schniepp, Distinguished Fellow, Regulatory Compliance Associates, joins PDA CEO Glenn Wright and Melissa Seymour, Executive Vice President, Global Quality, Eli Lilly and Company, to talk about the regulatory and quality topics discussed at the 2025 PDA Regulatory Conference.

PDA 2025: Strategic AI Adoption in Bio/Pharma Manufacturing

September 10th 2025

AI can offer a strategic blueprint for GxP compliance, risk mitigation, and human-led operational excellence.

PDA 2025: FDA Experts’ Proactive Strategies for Mastering 483 Responses

September 10th 2025

FDA experts at PDA 2025 urges pharma to adopt holistic quality systems, strengthening 483 responses & post-warning letter remediation for compliance excellence.

AI and Digital Oversight in Pharma Supply Chains: PDA Regulatory Conference Insights

September 9th 2025

PDA Regulatory Conference

Charles Gibbons of Lachman Consultants and Michael Grischeau of AbbVie stressed AI governance, data integrity, and human oversight as essential to applying digital tools across labs and supply chains.